[Cleavage and biotransformation of the central muscle relaxant chlormezanone]. 1998

H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
Institut für Pharmazie, Friedrich-Schiller-Universität, Jena, Germany.

Chlormezanone, a chiral centrally acting muscle relaxant, will be cleaved at its S-C-1 bond by an autoprotolytic process. The optimum of chemical stability exists between pH 2 up to pH 9 with a maximum at pH 7.4. The plasma half life at 37 degrees C is 76 h. Enzymes do attack the products of cleavage namely 4-chlorobenzaldehyde and 2-carboxyethane-sulfinic-acid-N-methyl-amide. The main metabolite in urine is 4-chlorohippuric acid in the range of up to 70% of the oral administered dose to humans. No cytochrome P-450 is engaged in the cleavage of the S-C-bond.

UI MeSH Term Description Entries
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D002720 Chlormezanone A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm. Chlormethazanone
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
April 2000, Die Pharmazie,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
January 1961, New York state journal of medicine,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
April 1961, El Dia medico,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
November 1960, Svenska lakartidningen,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
January 1962, Clinical medicine (Northfield, Ill.),
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
October 1959, American practitioner and digest of treatment,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
September 1970, Neuropharmacology,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
April 1961, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
March 1966, Japanese journal of pharmacology,
H Oelschläger, and W Klinger, and D Rothley, and A Seeling, and H Bockhard, and B Hofmann, and H Machts, and H Riederer, and H Rackur
January 1967, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!